MEDICAL SUPERVISION AND PROFESSIONAL OVERSIGHT REQUIREMENTS FOR GENETIC TESTING IN INDIA

1. INTRODUCTION

Medical supervision requirements for genetic tests establish the professional, ethical and legal safeguards governing the collection, examination, interpretation and communication of human genetic information. Genetic testing includes diagnostic testing, carrier screening, prenatal genetic testing, predictive testing, pharmacogenomic testing and whole-genome sequencing.

These tests may reveal inherited diseases, reproductive risks, predisposition to cancer and other hereditary conditions. Incorrect interpretation, unauthorized testing, inadequate counselling and disclosure of confidential genetic information can cause serious medical and social consequences.

India does not have one comprehensive standalone statute governing all genetic tests. Instead, medical supervision is regulated through the Pre-Conception and Pre-Natal Diagnostic Techniques (Prohibition of Sex Selection) Act, 1994 (PCPNDT Act), applicable medical and laboratory regulations, ICMR ethical guidelines, professional standards and constitutional protections.

2. LEGAL AND REGULATORY FRAMEWORK

A. PCPNDT ACT, 1994

The PCPNDT Act establishes specific requirements for prenatal genetic testing and prohibits sex selection.

Its important provisions include:

Section 3: Registration and qualification requirements for genetic counselling centres, genetic laboratories and genetic clinics.

Section 4: Regulation of prenatal diagnostic techniques and their permitted medical purposes.

Section 5: Written consent requirements and prohibition on communicating fetal sex.

Section 6: Prohibition of sex selection.

Section 18: Registration of genetic counselling centres, laboratories and clinics.

Section 23: Penalties for offences under the Act.

These provisions require appropriate professional supervision and institutional accountability for covered prenatal diagnostic activities.

B. PCPNDT RULES, 1996

Rule 3 establishes qualification and equipment requirements for genetic counselling centres, genetic laboratories and genetic clinics. Medical geneticists, appropriately qualified gynaecologists, paediatricians and laboratory personnel must satisfy the applicable requirements.

Rule 10 establishes written-consent requirements for specified prenatal diagnostic procedures. Rule 9 addresses the maintenance and preservation of prescribed records.

C. DRUGS AND COSMETICS ACT, 1940

Where genetic testing involves regulated diagnostic products or medical devices, applicable requirements under the Drugs and Cosmetics Act, 1940 and Medical Devices Rules, 2017 become relevant.

D. ICMR ETHICAL GUIDELINES

The ICMR National Ethical Guidelines for Biomedical and Health Research involving Human Participants establish safeguards concerning informed consent, confidentiality, ethical review, participant protection and responsible research conduct.

E. CONSTITUTIONAL PROTECTION

Article 21 protects personal liberty, privacy and bodily autonomy. Article 14 protects individuals against arbitrary and discriminatory treatment. These constitutional principles are particularly important when genetic information is collected, processed or disclosed.

3. MEDICAL SUPERVISION REQUIREMENTS

A. QUALIFIED MEDICAL PROFESSIONALS

Genetic tests requiring clinical interpretation should involve appropriately qualified medical professionals. Genetic counselling should be provided by professionals satisfying applicable qualifications and competency requirements.

B. PRE-TEST COUNSELLING

Before testing, patients should receive information concerning the purpose, limitations, possible outcomes, incidental findings and medical implications of the proposed test.

C. INFORMED CONSENT

Consent must be voluntary and based on adequate information. Patients should understand the nature of the test, potential risks, available alternatives and consequences of receiving or declining results.

D. LABORATORY SUPERVISION

Testing facilities should maintain qualified personnel, validated procedures, sample identification systems, quality-control mechanisms and accurate reporting procedures.

E. POST-TEST MEDICAL INTERPRETATION

Genetic results should be interpreted in their clinical context. A genetic variant must not automatically be treated as proof of an existing disease. Appropriate confirmatory testing and specialist referral may be necessary.

F. CONFIDENTIALITY

Genetic information should be protected against unauthorized disclosure. Applicable data-protection requirements, including the Digital Personal Data Protection Act, 2023, must be considered.

4. RELEVANT JUDICIAL DECISIONS

There is no established Supreme Court judgment specifically prescribing a comprehensive supervision framework for all genetic tests. The following decisions provide direct or analogous legal principles.

1. Samira Kohli v. Dr. Prabha Manchanda (2008) — Direct medical-consent authority

The Supreme Court explained that valid medical consent must be voluntary, given by a competent person and based on adequate information. This principle applies to genetic testing before conducting procedures beyond the patient's authorization.

2. K.S. Puttaswamy v. Union of India (2017) — Direct privacy authority

The Supreme Court recognized privacy as a fundamental right under Article 21. Its principles are relevant to genetic information, genomic databases, confidentiality and unauthorized genetic profiling.

3. Sharda v. Dharmpal (2003) — Analogous authority

The Supreme Court examined the circumstances in which courts may direct medical examinations in matrimonial proceedings. The decision demonstrates the need to balance medical investigation, privacy and competing legal interests.

4. CEHAT v. Union of India (2001) — Direct prenatal diagnostic regulatory authority

The Supreme Court emphasized strict implementation of the PCPNDT Act and action against unregistered genetic counselling centres, laboratories and clinics. It reinforces institutional registration and regulatory supervision.

5. Voluntary Health Association of Punjab v. Union of India (2013) — Direct prenatal diagnostic regulatory authority

The Supreme Court issued directions for effective implementation of the PCPNDT Act, including monitoring, record maintenance, inspections and enforcement against illegal prenatal diagnostic practices.

6. Jacob Puliyel v. Union of India (2022) — Analogous authority

The Supreme Court considered bodily autonomy, informed choice and public-health regulation in the context of vaccination policy. Its reasoning is relevant to evaluating individual choice and medical supervision in genetic testing.

7. Indian Medical Association v. V.P. Shantha (1995) — Analogous authority

The Supreme Court recognized the applicability of consumer protection principles to qualifying medical services. Negligent genetic diagnosis, deficient professional services or misleading medical representations may raise similar liability questions.

5. LIABILITY AND ENFORCEMENT

Medical professionals and genetic testing institutions may face:

Civil liability for negligent testing, interpretation or counselling.

Criminal liability where applicable statutory offences are established.

Professional disciplinary action for professional misconduct.

Regulatory penalties for violations of the PCPNDT Act.

Consumer protection liability for deficiency in qualifying medical services.

Data-protection liability for unlawful processing or disclosure of genetic information.

6. PRACTICAL COMPLIANCE REQUIREMENTS

Genetic testing institutions should maintain:

Valid institutional registration wherever legally required.

Documented professional qualifications and supervisory responsibilities.

Written informed-consent documentation.

Pre-test and post-test counselling arrangements.

Validated laboratory testing and quality-control records.

Secure storage and controlled access to genetic information.

Accurate reports and appropriate specialist referrals.

Prescribed prenatal diagnostic records and regulatory submissions.

7. CONCLUSION

Medical supervision is essential for ensuring the safety, accuracy, confidentiality and ethical legitimacy of genetic testing. Indian law establishes particularly detailed requirements for prenatal genetic testing through the PCPNDT Act and Rules, while other genetic testing activities are governed through applicable medical, laboratory, professional, research and data-protection frameworks.

The judicial principles established in Samira Kohli, Puttaswamy, Sharda, CEHAT and Voluntary Health Association of Punjab strengthen the requirements of informed consent, privacy, institutional accountability and regulatory enforcement.

Ultimately, genetic testing must remain under appropriate professional oversight, supported by scientifically reliable laboratory procedures, informed patient consent, responsible interpretation and strict protection of genetic information.